These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

175 related items for PubMed ID: 7513911

  • 1. FK506 conversion therapy in pediatric liver transplantation.
    Egawa H, Esquivel CO, So SK, Cox K, Concepcion W, Lawrence L.
    Transplantation; 1994 Apr 27; 57(8):1169-73. PubMed ID: 7513911
    [Abstract] [Full Text] [Related]

  • 2. Initial experience with FK506 (tacrolimus) in pediatric renal transplant recipients.
    McKee M, Segev D, Wise B, Case B, Neu A, Fivush B, Colombani P.
    J Pediatr Surg; 1997 May 27; 32(5):688-90. PubMed ID: 9165452
    [Abstract] [Full Text] [Related]

  • 3. Long-term outcomes in pediatric liver recipients: comparison between cyclosporin A and tacrolimus.
    Cao S, Cox KL, Berquist W, Hayashi M, Concepcion W, Hammes GB, Ojogho OK, So SK, Frerker M, Castillo RO, Monge H, Esquivel CO.
    Pediatr Transplant; 1999 Feb 27; 3(1):22-6. PubMed ID: 10359027
    [Abstract] [Full Text] [Related]

  • 4. Long-term results after conversion from cyclosporine to tacrolimus in pediatric liver transplantation for acute and chronic rejection.
    Reyes J, Jain A, Mazariegos G, Kashyap R, Green M, Iurlano K, Fung J.
    Transplantation; 2000 Jun 27; 69(12):2573-80. PubMed ID: 10910279
    [Abstract] [Full Text] [Related]

  • 5. The treatment of intractable rejection with tacrolimus (FK506) in pediatric liver transplant recipients.
    McDiarmid SV, Wallace P, Vargas J, Ament ME, Busuttil RW.
    J Pediatr Gastroenterol Nutr; 1995 Apr 27; 20(3):291-9. PubMed ID: 7541834
    [Abstract] [Full Text] [Related]

  • 6. Rejection and tacrolimus conversion therapy in paediatric liver transplantation.
    Spada M, Corno V, Colledan M, Segalin A, Lucianetti A, Torre G, Riva S, Sonzogni A, Petz W, Gridelli B.
    Transpl Int; 2000 Apr 27; 13 Suppl 1():S341-4. PubMed ID: 11112028
    [Abstract] [Full Text] [Related]

  • 7. A multicenter analysis of the first experience with FK506 for induction and rescue therapy after pancreas transplantation.
    Gruessner RW, Burke GW, Stratta R, Sollinger H, Benedetti E, Marsh C, Stock P, Boudreaux JP, Martin M, Drangstveit MB, Sutherland DE, Gruessner A.
    Transplantation; 1996 Jan 27; 61(2):261-73. PubMed ID: 8600635
    [Abstract] [Full Text] [Related]

  • 8. Conversion of liver allograft recipients from cyclosporine to FK506 immunosuppressive therapy--a clinicopathologic study of 96 patients.
    Demetris AJ, Fung JJ, Todo S, McCauley J, Jain A, Takaya S, Alessiani M, Abu-Elmagd K, Van Thiel DH, Starzl TE.
    Transplantation; 1992 May 27; 53(5):1056-62. PubMed ID: 1374944
    [Abstract] [Full Text] [Related]

  • 9. Conversion from cyclosporine to FK506 for salvage of immunocompromised pediatric liver allografts. Efficacy, toxicity, and dose regimen in 23 children.
    Reding R, Wallemacq PE, Lamy ME, Rahier J, Sempoux C, Debande B, Jamart J, Barker A, Sokal E, De Ville de Goyet J.
    Transplantation; 1994 Jan 27; 57(1):93-100. PubMed ID: 7507272
    [Abstract] [Full Text] [Related]

  • 10. Management of acute steroid-resistant rejection after liver transplantation.
    Platz KP, Mueller AR, Zytowski M, Lemmens P, Lobeck H, Neuhaus P.
    World J Surg; 1996 Oct 27; 20(8):1052-8; discussion 1058-9. PubMed ID: 8798364
    [Abstract] [Full Text] [Related]

  • 11. Rescue FK506 early conversion for refractory rejection after pediatric liver transplantation: experience in 20 children.
    Reggiani P, Gridelli B, Colledan M, Rossi G, Lucianetti A, Galmarini D, Fassati LR.
    Transpl Int; 1998 Oct 27; 11 Suppl 1():S272-4. PubMed ID: 9664995
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Tacrolimus as a rescue immunosuppressant after heart transplantation.
    De Bonis M, Reynolds L, Barros J, Madden BP.
    Eur J Cardiothorac Surg; 2001 May 27; 19(5):690-5. PubMed ID: 11343954
    [Abstract] [Full Text] [Related]

  • 14. Basiliximab (Simulect) for the treatment of steroid-resistant rejection in pediatric liver transpland recipients: a preliminary experience.
    Aw MM, Taylor RM, Verma A, Parke A, Baker AJ, Hadzic D, Muiesan P, Rela M, Heaton ND, Mieli-Vergani G, Dhawan A.
    Transplantation; 2003 Mar 27; 75(6):796-9. PubMed ID: 12660504
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. FK506 "rescue" for resistant rejection of renal allografts under primary cyclosporine immunosuppression.
    Jordan ML, Shapiro R, Vivas CA, Scantlebury VP, Rhandhawa P, Carrieri G, McCauley J, Demetris AJ, Tzakis A, Fung JJ.
    Transplantation; 1994 Mar 27; 57(6):860-5. PubMed ID: 7512293
    [Abstract] [Full Text] [Related]

  • 17. FK506 (tacrolimus) compared with cyclosporine for primary immunosuppression after pediatric liver transplantation. Results from the U.S. Multicenter Trial.
    McDiarmid SV, Busuttil RW, Ascher NL, Burdick J, D'Alessandro AM, Esquivel C, Kalayoglu M, Klein AS, Marsh JW, Miller CM.
    Transplantation; 1995 Feb 27; 59(4):530-6. PubMed ID: 7533345
    [Abstract] [Full Text] [Related]

  • 18. Comparison of FK506- and cyclosporine-based immunosuppression in primary orthotopic liver transplantation. A single center experience.
    Neuhaus P, Blumhardt G, Bechstein WO, Platz KP, Jonas S, Mueller AR, Langrehr JM, Lohmann R, Schattenfroh N, Knoop M.
    Transplantation; 1995 Jan 15; 59(1):31-40. PubMed ID: 7530868
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. FK506 conversion for intractable rejection of the liver allograft.
    McDiarmid SV, Klintmalm GB, Busuttil RW.
    Transpl Int; 1993 Jan 15; 6(6):305-12. PubMed ID: 7507675
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.